STADA NORDIC ApS: Financial statements 2022
CVR: 13902992
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
STADA NORDIC ApS (CVR 13902992) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 677,719,089 and a net result of DKK 62,682,562 compared with DKK 28,828,665 the year before. That is an increase of 46.4% compared with the year before. The profit margin was 9.2%. Equity in the 2022 report amounted to DKK 179,244,701. The solvency ratio was 44.2%. The company had 36 employees in the financial year.
- Revenue
- DKK 677,719,089
- Gross Profit
- DKK 313,945,159
- Profit/Loss
- DKK 62,682,562
- Equity
- DKK 179,244,701
- Total Assets
- DKK 405,629,539
- Employees
- 36
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 677.7 mio. | 313.9 mio. | 62.7 mio. | 179.2 mio. | 36 |
| 2021 | 462.8 mio. | 227.5 mio. | 28.8 mio. | 116.6 mio. | 24 |
| 2020 | 494.6 mio. | 286.7 mio. | 20.9 mio. | 87.7 mio. | 20 |
| 2019 | 369.6 mio. | 201.6 mio. | 8.9 mio. | 66.8 mio. | 15 |
| 2018 | 292.2 mio. | 126.7 mio. | 4.3 mio. | 95.3 mio. | 19 |
Official annual report
Keep an eye on STADA NORDIC ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
STADA NORDIC ApS has published its annual report for 2021. Revenue came to DKK 462,792,525, and the net result was DKK 28,828,665.
About STADA NORDIC ApS
STADA NORDIC ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 1990. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named PHARMACODANE ApS and ApS KBIL 15 NR. 1160. The management consists of Inge-Merete Larsen. The board consists of Berit Goldmann. The company is owned by BEPHA Beteiligungsgesellschaft für Pharmawerte GmbH. The company has 49 employees (2026). In 2025, the company reported revenue of DKK 1,296,878,325 and a net result of DKK 54,568,326 compared with DKK 46,128,280 the year before. Equity in the 2025 report amounted to DKK 346,297,970.